glp-1 medication fatigue management strategies This One Mistake Puts Users at Risk of Fatigue, Weakness, and Weight Regain The GLP-1 Struggle: Daily Fatigue

Exenatide The FDA OKd exenatide in 2005, making it the first approved GLP-1 for Type 2 diabetes

Some patients find their maintenance dose is only one step below their therapeutic dose

The combination also increases the risk of nausea and can further stress the GI tract during the window when side effects are already most likely

Methylmalonic acid is a more sensitive marker of functional B12 status Complete blood count (CBC): Establishes baseline red blood cell parameters for monitoring anemia development Iron panel (ferritin, serum iron, TIBC): Ferritin below 30 ng/mL suggests depleted stores even with normal hemoglobin Comprehensive metabolic panel: Includes calcium, magnesium (though serum magnesium is imperfect), and kidney function RBC magnesium: More accurate than serum magnesium